Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 20 | 0 | 0 | 0 | €224.80 | €216.62 | -3.637% |
| Repligen Corp. | 14 | 0 | 0 | 0 | €130.90 | €180.11 | 37.594% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,043.0 | €1,087.6 | 4.272% |
| Radnet Inc. | 11 | 2 | 1 | 0 | €55.50 | €58.05 | 4.591% |
| R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.60 | €17.21 | 36.608% |
| QuidelOrtho Corp. | 9 | 2 | 2 | 0 | €40.60 | €59.81 | 47.312% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €138.95 | €145.02 | 4.367% |
| QIAGEN NV | 12 | 0 | 0 | 0 | €40.47 | €47.52 | 17.415% |
| Purple Biotech Ltd. ADR | 7 | 0 | 1 | 0 | €0.39 | €9.21 | 2236.802% |
| PTC Therapeutics Inc. | 17 | 9 | 4 | 0 | €28.00 | €41.46 | 48.082% |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | €18.40 | €78.70 | 327.720% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.71 | €2.32 | 35.719% |
| Pro-Dex Inc. | 13 | 0 | 3 | 0 | €20.80 | €27.17 | 30.630% |
| Precision BioSciences Inc | 9 | 0 | 1 | 0 | €0.35 | €17.75 | 5001.609% |
| Pfizer Inc. | 31 | 4 | 6 | 0 | €26.65 | €41.10 | 54.233% |
| Personalis Inc | 11 | 1 | 4 | 0 | €4.82 | €7.29 | 51.136% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €24.13 | €35.01 | 45.070% |
| PerkinElmer Inc. | 1 | 0 | 1 | 0 | €107.60 | €120.50 | 11.989% |
| Paul Hartmann AG | 4 | 0 | 1 | 0 | €198.50 | - | - |
| Omnicell Inc. | 3 | 2 | 0 | 0 | €40.60 | €36.81 | -9.339% |
| Omeros Corp. | 2 | 2 | 0 | 0 | €3.20 | - | - |
| Ocular Therapeutix Inc. | 15 | 4 | 0 | 0 | €7.57 | €13.09 | 72.956% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €118.00 | €145.50 | 23.305% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Novocure Ltd | 1 | 0 | 0 | 0 | €15.25 | - | - |